IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
Accelerated Cure Project for Multiple Sclerosis · with Patient-Centered Outcomes Research Institute, Ogilvy · NCT02486562
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 20000
- US sites recruiting
- 1
- Study start
- November 2014
- Record last updated
- February 18, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
iConquerMS™ is a research initiative developed by and for people with multiple sclerosis (MS) to contribute their health data and ideas to advance and accelerate research into MS. iConquerMS welcomes adults with MS and others interested in advancing MS research, children and teens with MS and their family members (via iConquerMS Kids \& Teens) and MS caregivers (via iConquerMS Caregivers) to participate.
Conditions: Multiple Sclerosis
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 21 years of age or older at the time of informed consent or under 21 with parental consent and participant assent.
Exclusion Criteria
- Unwilling or unable to provide informed consent.
Recruiting US locations
Accelerated Cure Project
Waltham, MA 02451
Site contact: Sara Loud, MS, MSEE · 781-487-0032 · sloud@acceleratedcure.org
Study contacts (from the official record)
- Sara Loud, MSEE, MBA · 781-487-0032 · sloud@acceleratedcure.org
Similar studies in Massachusetts
All neurology studies in Massachusetts →- RecruitingHealthy volunteersPhase 1
Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation
General Biophysics LLC
- Location
- Boston, MA
- Eligibility basics
- Ages 55–75
- RecruitingPhase 1/Phase 2Overnight stay mentioned
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Vector Y Therapeutics
- Location
- Boston, MA + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1
Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects
Massachusetts General Hospital
- Location
- Boston, MA
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersEarly Phase 1
Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease
Massachusetts General Hospital
- Location
- Boston, MA
- Eligibility basics
- Ages 40–99